Form 4: Silicon Laboratories CEO Robert Johnson Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Robert Johnson, CEO of Silicon Laboratories, reports acquisition and disposal of company stock, including shares withheld for taxes and sales under a 10b5-1 trading plan.

Summary

  • On May 15, 2025, Robert Matthew Johnson, the President & CEO of Silicon Laboratories Inc., acquired 39,282 shares of common stock at $0 via restricted stock units (RSUs).
  • These RSUs vest in three equal installments on the first three anniversaries of the grant date.
  • Also on May 15, 2025, 7,625 shares were disposed of at $133.17 to cover taxes related to the vesting of a previous equity award.
  • On May 16, 2025, Johnson sold 5,879 shares at $131.2 per share under a pre-arranged 10b5-1 trading plan.
  • Following these transactions, Johnson directly owns 73,688 shares of Silicon Laboratories Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing primarily reports routine stock transactions by the CEO, including grants, tax-related disposals, and sales under a pre-arranged trading plan. There is no indication of unusual or concerning activity.

Future Outlook

The restricted stock units will vest in three equal installments on the first three anniversaries of the grant date.

Industry Context

Executive stock transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects.

Comparison to Industry Standards

  • Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
  • Sales under 10b5-1 trading plans are common and allow insiders to sell shares at predetermined times to avoid accusations of insider trading.
  • Comparable companies like Texas Instruments (TXN) and Analog Devices (ADI) also have executives who regularly report stock transactions.

Stakeholder Impact

  • The stock transactions may have a minor impact on shareholders due to the increased number of shares in the market.
  • The vesting of RSUs incentivizes the CEO to improve company performance, which benefits shareholders.

Key Dates

DateDescription
05/15/2025Grant of restricted stock units (RSUs) and shares withheld for taxes.
05/16/2025Sale of shares pursuant to 10b5-1 Trading Plan.
05/19/2025Date of signature for the Form 4 filing.

Keywords

Form 4, Robert Johnson, Silicon Laboratories, SLAB, Stock Transactions, CEO, Restricted Stock Units, 10b5-1 Trading Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.